Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

906 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Maximizing the cost-effectiveness of lipid-lowering therapy.
Jacobson TA, Schein JR, Williamson A, Ballantyne CM. Jacobson TA, et al. Among authors: ballantyne cm. Arch Intern Med. 1998 Oct 12;158(18):1977-89. doi: 10.1001/archinte.158.18.1977. Arch Intern Med. 1998. PMID: 9778197 Review.
Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels.
Ballantyne CM, Andrews TC, Hsia JA, Kramer JH, Shear C; ACCESS Study Group. Atorvastatin Comparative Cholesterol Efficacy and Safety Study. Ballantyne CM, et al. Am J Cardiol. 2001 Aug 1;88(3):265-9. doi: 10.1016/s0002-9149(01)01638-1. Am J Cardiol. 2001. PMID: 11472705 Clinical Trial.
Current thinking in lipid lowering.
Ballantyne CM. Ballantyne CM. Am J Med. 1998 Jun 22;104(6A):33S-41S. doi: 10.1016/s0002-9343(98)00186-7. Am J Med. 1998. PMID: 9684850 Review.
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM. Barter PJ, et al. Among authors: ballantyne cm. J Intern Med. 2006 Mar;259(3):247-58. doi: 10.1111/j.1365-2796.2006.01616.x. J Intern Med. 2006. PMID: 16476102
906 results